Affiliation:
1. Department of Pediatrics, Hematology/Oncology Unit, University General Hospital of Alexandroupolis, 68 100 Alexandroupolis, Greece
Abstract
Iron deficiency (ID) is by far the most common nutritional disorder in developing and developed countries. When left untreated, ID leads to anemia. Although the usually recommended treatment for iron deficiency anemia (IDA) is oral iron therapy with countless products, such therapy necessitates administration for >3–6 months with questionable patient compliance since most oral iron products have an unpleasant metallic aftertaste and cause intestinal side effects. In addition, in certain gastrointestinal conditions, such as inflammatory bowel diseases or untreated gluten-sensitive enteropathy, oral iron therapy is contraindicated or unsuccessful. Intravenous iron is considered safe in adults, where adverse events are mild and easily managed. The experience with parenteral iron in children is much more limited, and many pediatricians appear reluctant to use it because of uncorroborated fears of serious anaphylactic reactions. In the current article, we thoroughly review the available pediatric literature on the use of all commercially available parenteral iron products except ferumoxytol, which was recently removed from the market. We conclude that parenteral iron appears to be safe in children; it works faster than oral iron, and the newer third-generation products allow replacement of the total iron deficit in a single sitting.
Reference69 articles.
1. Iron deficiency anemia in children residing in high and low-income countries: Risk factors, prevention, diagnosis and therapy;Mantadakis;Mediterr. J. Hematol. Infect. Dis.,2020
2. Secular Trends in the Prevalence of Iron Deficiency Among US Toddlers, 1976–2002;Brotanek;Arch. Pediatr. Adolesc. Med.,2008
3. Management of iron deficiency anemia: A survey of pediatric hematology/oncology specialists;Powers;Pediatr. Blood Cancer,2015
4. Tolkien, Z., Stecher, L., Mander, A.P., Pereira, D.I.A., and Powell, J.J. (2015). Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis. PLoS ONE, 10.
5. Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: A real-world evidence study;Fiorino;Ther. Adv. Gastroenterol.,2023